Loading...

Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma (MCL)

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Haematol
Main Authors: Jiang, Huijuan, Lwin, Tint, Zhao, Xiaohong, Ren, Yuan, Li, Grace, Moscinski, Lynn, Shah, Bijal, Tao, Jianguo
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066460/
https://ncbi.nlm.nih.gov/pubmed/29383700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15079
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!